Roth Capital analyst Yasmeen Rahimi reiterated a Buy rating on Galectin Therapeutics (NASDAQ: GALT) on November 14 and set a
Today, the SVP-Corporate Development of Danaher Corp, Daniel Raskas, exercised options of Danaher Corp for $3.53M. Following Daniel Raskas’ last
Today, the SVP, GM – Oncology of Angiodynamics, Stark Richard, exercised options of Angiodynamics for $446.5K. ANGO’s market cap is
Today, the VP R&D of Cryolife, David C. Gale, exercised options of Cryolife for $392.4K. In addition to David C.
Today, a Director at T2 Biosystems (NASDAQ: TTOO), David Elsbree, bought shares of TTOO for $6,165. This recent transaction increases
In a report released yesterday, Matthew Mishan from KeyBanc reiterated a Hold rating on Teleflex Inc (NYSE: TFX). The company’s
Maxim Group analyst Jason McCarthy assigned a Buy rating to Bluebird Bio (NASDAQ: BLUE) today and set a price target